BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 238144)

  • 1. Proceedings: Influence of H44/68 and FLA63 on central catecholamines and motor activity under light and darkness.
    Lemmer B; Berger T
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R13. PubMed ID: 238144
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of inhibitors of the catecholamine synthesis on motor activity in the rat during light and darkness.
    Berger T; Lemmer B
    Pol J Pharmacol Pharm; 1976; 28(6):601-3. PubMed ID: 1012983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
    Dolphin A; Jenner P; Marsden CD
    Br J Pharmacol; 1975 Jun; 54(2):246P-247P. PubMed ID: 1148534
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of the dopamine-beta-hydroxylase inhibitor FLA 63 on the kinetics of elimination of amphetamine in the rat.
    Jonsson J; Lewander T
    J Pharm Pharmacol; 1974 Nov; 26(11):907-9. PubMed ID: 4156566
    [No Abstract]   [Full Text] [Related]  

  • 5. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 6. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
    Kokkinidis L; Irwin J; Anisman H
    Neuropharmacology; 1979 Jan; 18(1):13-22. PubMed ID: 33347
    [No Abstract]   [Full Text] [Related]  

  • 7. Stress-related effects of various inhibitors of catecholamine synthesis in the mouse.
    Thornburg JE; Moore KE
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):158-67. PubMed ID: 4399378
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
    Antelman SM; Szechtman H; Chin P; Fisher AE
    J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of inhibition of dopamine beta-hydroxylase evoked by FLA-63. An in vitro study.
    Brodde OE; Nagel M; Schümann HJ
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):184-90. PubMed ID: 921409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of some dopamine-beta-hydroxylase inhibitors on the control mechanisms of the estrous cycle in rats.
    Kun I
    Endocrinologie; 1978; 16(4):263-8. PubMed ID: 569899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the dopamine-beta-hydroxylase inhibitor FLA 63 on the disposition of barbitone in the mouse.
    Sharkawi M
    J Pharm Pharmacol; 1979 May; 31(5):340-1. PubMed ID: 37309
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Biochemical evidence for the involvement of noradrenaline in motor activity produced by L-DOPA in rodents.
    Dolphin A; Jenner P; Marsden CD
    Br J Pharmacol; 1975 Oct; 55(2):292P. PubMed ID: 1201420
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence of a role for brain monoamines in ethanol dependence.
    Griffiths PJ; Littleton JM; Oritz A; Brownlee G
    Br J Pharmacol; 1973 Jun; 48(2):354P. PubMed ID: 4147432
    [No Abstract]   [Full Text] [Related]  

  • 14. [The brain catecholamine systems in the regulation of dominance].
    Serova LI; Naumenko EV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(3):490-6. PubMed ID: 1975967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of reserpine, tranylcypromine, haloperidol and FLA-63 on physostigmine--induced hyperactivity in rats.
    Wray SR; Egbe PC
    West Indian Med J; 1980 Mar; 29(1):60-6. PubMed ID: 7385820
    [No Abstract]   [Full Text] [Related]  

  • 16. Some effects of caffeine and aminophylline on the turnover of catecholamines in the brain.
    Waldeck B
    J Pharm Pharmacol; 1971 Nov; 23(11):824-30. PubMed ID: 4400189
    [No Abstract]   [Full Text] [Related]  

  • 17. Pentazocine analgesia and regional rat brain catecholamines.
    Paalzow G; Paalzow L; Stalby B
    Eur J Pharmacol; 1974 Jun; 27(1):78-88. PubMed ID: 4152989
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological and metabolic interactions between ethanol and the dopamine-beta-hydroxylase inhibitor FLA 63 in mice.
    Sharkawi M
    Neuropharmacology; 1980 Mar; 19(3):277-80. PubMed ID: 6999373
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of various inhibitors of tyrosine hydroxylase and dopamine beta-hydroxylase on rat self-stimulation after reserpine treatment.
    Stinus L; Thierry AM; Cardo B
    Psychopharmacologia; 1976 Feb; 45(3):287-94. PubMed ID: 2944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat.
    Dolphin A; Jenner P; Marsden CD
    J Pharm Pharmacol; 1978 Sep; 30(9):580-2. PubMed ID: 29100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.